Concepedia

Anasuya Vishvanath

AV

Statistics

Publications

7

Citations

443

H-Index

7

Active since

2004

Affiliations

Victoria University of Wellington(Current)

Gillies McIndoe Research Institute

Hutt Hospital

University of South Florida

Moffitt Cancer Center

Anasuya Vishvanath is an author at Victoria University of Wellington specializing in pharmacology, cell biology, and medicine.

Publications per year

2004–2014

7

Publications

7

Superior Activity of the Combination of Histone Deacetylase Inhibitor LAQ824 and the FLT-3 Kinase Inhibitor PKC412 against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3

Purva Bali, Prince George, Pamela Cohen et al. · Clinical Cancer Research · 2004 · 125 citations · Full text

, , +17

Cotreatment with 17-Allylamino-Demethoxygeldanamycin and FLT-3 Kinase Inhibitor PKC412 Is Highly Effective against Human Acute Myelogenous Leukemia Cells with Mutant FLT-3

Prince George, Purva Bali, Pamela Cohen et al. · Cancer Research · 2004 · 122 citations · Full text

, , +17

High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)

Leanna Cheung, Claudia L. Flemming, Fujiko Watt et al. · Biochemical Pharmacology · 2014 · 70 citations · Full text

, , +8

Infantile haemangioma expresses embryonic stem cell markers

Tinte Itinteang, Swee T. Tan, Helen D. Brasch et al. · Journal of Clinical Pathology · 2012 · 46 citations

, , +14

Mesenchymal stem cells in infantile haemangioma

Tinte Itinteang, Anasuya Vishvanath, Darren J. Day et al. · Journal of Clinical Pathology · 2011 · 34 citations

, , +16

1–5 of 7